Harpoon Therapeutics Presents Data for New ProTriTAC™

Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic...

Related Keywords

United States , American , Roberth Uhl , S Jack Lin , Luke Walker , Harpoon Therapeutics Inc , Nasdaq , American Association For Cancer Research , Preclinical Development , Exchange Commission , American Association , Cancer Research , Annual Meeting , Chief Medical Officer , Senior Director , Activating Construct , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic , Nasdaq Harp , Carp , Rotritac , Racr , T Cell ,